Our Work

Our latest Diabetes Drug Insights study follows a group of more than n=3,000 people with type 2 diabetes in the USA from 2018 to 2024.

The European Association for the Study of Diabetes (EASD) recently concluded in Vienna, marking an exceptional year of innovation and collaboration in diabetes research. EASD convenes top minds from around the world to set the course for diabetes care. We were proud to showcase our latest findings from the dQ&A team, now available as a downloadable poster.

For over 12 years, dQ&A has gathered primary data from diabetes healthcare practitioners (HCPs)—notably endocrinologists and primary care physicians—expanding our ‘Prescriber Perspectives’ tracker to five countries with insights from key prescribers and influencers.